Related Experiment Videos
Pituitary pathology in Carney complex patients.
Sotirios G Stergiopoulos1, Mones S Abu-Asab, Maria Tsokos
1Section on Endocrinology & Genetics, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1862, USA.
Pituitary
|March 12, 2005
Summary
Carney complex (CNC) involves pituitary tumors caused by PRKAR1A gene mutations. Loss of the normal PRKAR1A allele in tumors suggests it acts as a tumor suppressor, leading to hyperplasia and potentially adenomas.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Carney complex (CNC) is a genetic disorder causing multiple tumors.
- CNC shares features with McCune-Albright syndrome (MAS) and multiple endocrine neoplasia type 1 (MEN 1).
- Pituitary tumors, particularly growth hormone (GH)-producing adenomas, occur in CNC patients.
Purpose of the Study:
- To investigate the role of the PRKAR1A gene in pituitary tumor development in Carney complex.
- To explore the relationship between PRKAR1A mutations, pituitary hyperplasia, and adenoma formation.
Main Methods:
- Analysis of PRKAR1A gene status (germline and somatic) in pituitary tumors from CNC patients.
- Histopathological examination of pituitary tissue to identify hyperplasia.
- Genetic analysis of tumor tissue for chromosomal changes.
Main Results:
- Half of CNC patients have germline inactivating PRKAR1A mutations.
- Loss of the normal PRKAR1A allele (loss-of-heterozygosity) was observed in pituitary tumors.
- Pituitary tissue showed hyperplasia, specifically in somatomammotrophs, preceding adenoma formation.
- GH-producing adenomas exhibited chromosomal abnormalities.
Conclusions:
- PRKAR1A acts as a tumor suppressor gene in CNC somatomammotrophs.
- PRKAR1A mutations initiate pituitary hyperplasia, which may progress to adenoma formation through accumulating somatic genetic changes.